GL1X · GenesisL1 explorer

Research workbench

EGFR kinase domain mutant "tmlr" with a imidazopyridinyl- aminopyrimidine inhibitor

Analyse EGFR kinase domain mutant "tmlr" with a imidazopyridinyl- aminopyrimidine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5HIC
Type
protein
Length
302 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Epidermal growth factor receptor
EC
2.7.10.1
UniProt
P00533
Ligands
63N, SO4
Pockets
3 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEpidermal growth factor receptor (EC 2.7.10.1)protein30237% helix, 18% strandP00533

Ligands and binding sites

  • 63N · N-{2-[1-(cyclopropylsulfonyl)-1H-pyrazol-4-yl]pyrimidin-4-yl}-1-(propan-2-yl)-1H-imidazo[4,5-c]pyridin-6-amine · ligand · chains A
  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14100.700.815263N
21750.540.7922empty
3910.400.7714empty

Compared structures

  • 5HIC · EGFR kinase domain mutant TMLR" with a imidazopyridinyl-aminopyrimidine inhibitor" · the same entry in another collection · chain A against A, TM-score 1.00
  • P00533 · AlphaFold monomer V2.0 prediction for epidermal growth factor receptor (P00533) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.